Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Blueprint Medicines (BPMC)
NASDAQ:BPMC
Holding BPMC?
Track your performance easily
Blueprint Medicines (BPMC) Ownership Overview
1.53% Insiders
43.35% Mutual Funds
23.35% Other Institutional Investors
17.59% ETFs
14.18% Public Companies and
Individual Investors
The ownership structure of Blueprint Medicines (BPMC) stock is a mix of institutional, retail, and individual investors. Approximately 84.29% of the company’s stock is owned by Institutional Investors, 1.53% is owned by Insiders, and 14.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 04, 2024 | Fouad Namouni President, R & D | xxxxxxxxxxxxx | $324500 |
| Aug 07, 2024 | Philina Lee Cco | xxxxxxxxxxxxx | $3905872 |
| Jun 07, 2024 | xxxxxxxxxxxxx | $420520 | |
| Jun 05, 2024 | xxxxxxxxxxxxx | $259263 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $396547 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1570372 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $31019875 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $41955965 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,959,505 | Institution | 9.38% | 532,779,747 | |
| 5,410,333 | Institution | 8.52% | 483,683,770 | |
| 2,988,333 | Institution | 4.70% | 267,156,970 | |
| 2,064,248 | Institution | 3.25% | 184,543,771 | |
| 1,511,267 | Institution | 2.38% | 135,107,270 | |
| 1,489,652 | Institution | 2.34% | 133,174,889 | |
| 1,461,318 | Institution | 2.30% | 130,641,829 | |
| 1,153,418 | Institution | 1.82% | 103,115,569 | |
| 913,796 | Institution | 1.44% | 81,693,362 | |
| 803,730 | Institution | 1.27% | 71,853,462 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,410,333 | Institution | 8.52% | 483,683,770 | |
| 2,064,248 | Institution | 3.25% | 184,543,771 | |
| 1,511,267 | Institution | 2.38% | 135,107,270 | |
| 1,489,652 | Institution | 2.34% | 133,174,889 | |
| 1,461,318 | Institution | 2.30% | 130,641,829 | |
| 913,796 | Institution | 1.44% | 81,693,362 | |
| 803,730 | Institution | 1.27% | 71,853,462 | |
| 775,117 | Institution | 1.22% | 69,295,460 | |
| 703,596 | Institution | 1.11% | 62,901,482 | |
| 687,295 | Institution | 1.08% | 61,444,173 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,988,563 | Institution | 3.13% | 174,019,148 | |
| 1,751,813 | Institution | 2.76% | 156,612,082 | |
| 1,588,795 | Institution | 2.50% | 139,035,450 | |
| 1,029,423 | Institution | 1.62% | 94,315,735 | |
| 945,651 | Institution | 1.49% | 82,753,919 | |
| 873,376 | Institution | 1.37% | 76,429,134 | |
| 578,393 | Institution | 0.91% | 51,708,334 | |
| 401,967 | Institution | 0.63% | 35,935,850 | |
| 306,907 | Institution | 0.48% | 28,118,819 | |
| 286,545 | Institution | 0.45% | 25,075,553 |
FAQ
Who Owns Blueprint Medicines (BPMC)?
According to the latest TipRanks data, approximately 23.35% of the company's stock is held by institutional investors, 1.53% is held by insiders, and 14.18% is held by retail investors.
What percentage of Blueprint Medicines (BPMC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 23.35% of Blueprint Medicines (BPMC) stock is held by institutional investors.
What percentage of Blueprint Medicines (BPMC) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.18% of Blueprint Medicines (BPMC) stock is held by retail investors.
Who owns the most shares of Blueprint Medicines (BPMC)?
Vanguard owns the most shares of Blueprint Medicines (BPMC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.